Oct 24 (Reuters) - Biotec Pharmacon ASA BIOTEC.OL :
* BIOTEC PHARMACON Q3 2019 REULTS
* Q3 SALES NOK 22.5 MILLION VERSUS NOK 22.1 MILLION YEAR AGO
* Q3 EBITDA NOK 0.8 MILLION VERSUS NOK 0.6 MILLION YEAR AGO
* OUTLOOK FOR 2019 HAS SLIGHTLY CHANGED: THE AIMS ARE TO GROW SALES ORGANICALLY ACROSS BOTH
DIVISIONS AND CONTINUE TO REDUCE CASH CONSUMPTION IN 2019
Source text for Eikon: ID:nWkr904XhV
Further company coverage: BIOTEC.OL
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))